Jordy Dekker

Jordy Dekker

Auto-generated profile, based on publicly available information

Jordy Dekker

Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, Rotterdam 3000 CA, the Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in European Journal of Paediatric Neurology
Verified
Journal Article
Open access
JDJordy Dekker
Jordy Dekker
KDKarin E.M. Diderich
Karin E.M. Diderich
RSRachel Schot
Rachel Schot
SHSofie C. Husen
Sofie C. Husen
MDMarjolein H.G. Dremmen
Marjolein H.G. Dremmen
GMGrazia M.S. Mancini
Grazia M.S. Mancini
TUBB2B codes for one of the isotypes of β-tubulin and dominant negative variants in this gene result in distinctive malformations of cortical development (MCD), including dysgyria, dysmorphic basal ganglia and cerebellar anomalies. We present a novel family with a heterozygous missense variant in TUBB2B and an unusually mild phenotype. First, at 21 37 weeks of gestation ultrasonography revealed a fetus with a relatively small head, enlarged lateral ventricles, borderline hypoplastic cerebellum and a thin corpus callosum. The couple opted for pregnancy termination. Exome sequencing on fetal material afterwards identified a heterozygous maternally inherited variant in TUBB2B (NM_178012.4 (TUBB2B):c.530A > T, p.(Asp177Val)), not present in GnomAD and predicted as damaging. The healthy mother had only a language delay in childhood. This inherited TUBB2B variant prompted re-evaluation of the older son of the couple, who presented with a mild delay in motor skills and speech. His MRI revealed mildly enlarged lateral ventricles, a thin corpus callosum, mild cortical dysgyria, and dysmorphic vermis and basal ganglia, a pattern typical of tubulinopathies. This son finally showed the same TUBB2B variant, supporting pathogenicity of the TUBB2B variant. These observations illustrate the wide phenotypic heterogeneity of tubulinopathies, including reduced penetrance and mild expressivity, that require careful evaluation in pre- and postnatal counseling.

1 November 2021 in European Journal of Paediatric Neurology
Verified
Journal Article
Open access
GMGrazia M.S. Mancini
Grazia M.S. Mancini
DSDaphne J. Smits
Daphne J. Smits
JDJordy Dekker
Jordy Dekker
RSRachel Schot
Rachel Schot
MWMarie Claire Y. de Wit
Marie Claire Y. de Wit
MWMartina Wilke
Martina Wilke
The increasing pace of gene discovery in the last decade has brought a major change in the way the genetic causes of brain malformations are being diagnosed. Unbiased genomic screening has gained the first place in the diagnostic protocol of a child with congenital (brain) anomalies and the detected variants are matched with the phenotypic presentation afterwards. This process is defined as "reverse phenotyping". Screening of DNA, through copy number variant analysis of microarrays and analysis of exome data on different platforms, obtained from the index patient and both parents has become a routine approach in many centers worldwide. Clinicians are used to multidisciplinary team interaction in patient care and disease management and this explains why the majority of research that has led to the discovery of new genetic disorders nowadays proceeds from clinical observations to genomic analysis and to data exchange facilitated by open access sharing databases. However, the relevance of multidisciplinary team interaction has not been object of systematic research in the field of brain malformations. This review will illustrate some examples of how diagnostically driven questions through multidisciplinary interaction, among clinical and preclinical disciplines, can be successful in the discovery of new genes related to brain malformations. The first example illustrates the setting of interaction among neurologists, geneticists and neuro-radiologists. The second illustrates the importance of interaction among clinical dysmorphologists for pattern recognition of syndromes with multiple congenital anomalies. The third example shows how fruitful it can be to step out of the "clinical comfort zone", and interact with basic scientists in applying emerging technologies to solve the diagnostic puzzles.

7 June 2022 in medRxiv
Verified
Preprint
Open access
PDF file
JDJordy Dekker
Jordy Dekker
RSRachel Schot
Rachel Schot
MBMichiel Bongaerts
Michiel Bongaerts
WVWalter G. de Valk
Walter G. de Valk
MVMonique M. van Veghel-Plandsoen
Monique M. van Veghel-Plandsoen
THTjakko J. van Ham
Tjakko J. van Ham
Background: For neurodevelopmental disorders (NDD), a molecular diagnosis is key for predicting outcome, treatment and genetic counseling. Currently, in about half of NDD cases, routine DNA-based testing fails to establish a genetic diagnosis. Transcriptome analysis (RNA-seq) improves the diagnostic yield for some groups of diseases, but has not been applied to NDD in a routine diagnostic setting. Methods: Here, we explored the diagnostic potential of RNA-seq in a cohort of 96 individuals including 67 undiagnosed NDD subjects. We created a user-friendly web-application to analyze RNA-seq data from single individuals’ cultured skin fibroblasts for genic, exonic and intronic expression outliers, based on modified OUTRIDER Z-scores. Candidate pathogenic events were complemented/matched with genomic data and, if required, confirmed with additional functional assays. Results: We identified pathogenic small genomic deletions, mono-allelic expression, aberrant splicing events, deep intronic variants resulting in pseudo-exon insertion, but also synonymous and nonsynonymous variants with deleterious effects on transcription. This approach increased the diagnostic yield for NDD by 12%. Diagnostic pitfalls during transcriptome analysis include detection of splice abnormalities in putative disease genes caused by benign polymorphisms and/or absence of expression of the responsible gene in the tissue of choice. This was misleading in one case and could have led to the wrong diagnosis in the absence of appropriate phenotyping. Conclusions: Nonetheless, our results demonstrate the utility of RNA-seq in molecular diagnostics and stress the importance of multidisciplinary team consultation. In particular, the approach is useful for the identification and interpretation of unexpected pathogenic changes in mRNA processing and expression in NDD.

8 September 2025 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
JDJordy Dekker
Jordy Dekker
RSRachel Schot
Rachel Schot
KAKimberly A. Aldinger
Kimberly A. Aldinger
DEDavid B. Everman
David B. Everman
CWCamerun Washington
Camerun Washington
GMGrazia M.S. Mancini
Grazia M.S. Mancini

23 September 2025 in The Microbe
Verified
Journal Article
Open access
JDJordy Dekker
Jordy Dekker
LDLaura M.L. Dix
Laura M.L. Dix